Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension.
Petkov, Ventzislav
Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension. [electronic resource] - The Journal of clinical investigation May 2003 - 1339-46 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0021-9738
10.1172/JCI17500 doi
Adult
Cell Division--physiology
Cells, Cultured
Exercise
Female
Hemodynamics
Humans
Hypertension, Pulmonary--blood
Immunohistochemistry
Lung--metabolism
Male
Middle Aged
Muscle, Smooth, Vascular--metabolism
Myocytes, Smooth Muscle--pathology
Radioligand Assay
Receptors, Vasoactive Intestinal Peptide--genetics
Receptors, Vasoactive Intestinal Peptide, Type II
Receptors, Vasoactive Intestinal Polypeptide, Type I
Vasoactive Intestinal Peptide--blood
Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension. [electronic resource] - The Journal of clinical investigation May 2003 - 1339-46 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0021-9738
10.1172/JCI17500 doi
Adult
Cell Division--physiology
Cells, Cultured
Exercise
Female
Hemodynamics
Humans
Hypertension, Pulmonary--blood
Immunohistochemistry
Lung--metabolism
Male
Middle Aged
Muscle, Smooth, Vascular--metabolism
Myocytes, Smooth Muscle--pathology
Radioligand Assay
Receptors, Vasoactive Intestinal Peptide--genetics
Receptors, Vasoactive Intestinal Peptide, Type II
Receptors, Vasoactive Intestinal Polypeptide, Type I
Vasoactive Intestinal Peptide--blood